The effect of pre-eclampsia on coagulation and fibrinolytic activation in the neonate

Thrombosis Research

Volumn 99, Issue 6, 2000, Pages 567-570

  Higgins, John R ^a   Bonnar, John ^b   Norris, Lucy A ^b   Darling, Michael R N ^a   Walshe, Joseph J ^a  

^a ROTUNDA HOSPITAL   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Coagulation; Fibrinolysis; Neonate; Pre eclampsia

Indexed keywords

ADULT; ARTICLE; BIRTH WEIGHT; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS CIRCULATION; FIBRINOLYSIS; HEMOSTASIS; HUMAN; NEWBORN; PLACENTA CIRCULATION; PREECLAMPSIA; PRIORITY JOURNAL;

ADULT; ANALYSIS OF VARIANCE; ANTIFIBRINOLYTIC AGENTS; ANTITHROMBIN III; BIRTH WEIGHT; BLOOD COAGULATION; FEMALE; FETAL BLOOD; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYSIS; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; PEPTIDE HYDROLASES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR;

EID: 0034666690     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00267-X     Document Type: Article

References (17)

1. Greer I.A. Hypertension. Calder A.A., Dunlop W. High risk pregnancy. 1995;71-115 Blackwell Science, Oxford.
2. Andrew M. Developmental hemostasis. relevance to thromboembolic complications in pediatric patients Thromb Haemost. 74:1995;415-425.
3. Spencer J.A., Smith M.J., Cederholm-Williams S.A., Wilkinson A.R. Influence of pre-eclampsia on concentrations of haemostatic factors in mothers and infants. Arch Dis Child. 58:1983;739-741.
4. Hathaway W.E., Mahasandana C., Makowski E.L. Cord blood coagulation studies in infants of high-risk pregnant women. Am J Obstet Gynecol. 121:1975;51-57.
5. Lox C.D., Word R.A., Corrigan J.J. Effects of preeclampsia on maternal and cord blood clotting activity. Am J Perinatol. 2:1985;279-282.
6. Condie R.G. Components of the haemostatic mechanism at birth in pre-eclampsia with particular reference to fetal growth retardation. Br J Obstet Gynaecol. 83:1976;943-947.
7. Pelzer H., Schwartz A., Heimburger N. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost. 59:1988;101-106.
8. Lancet. 2:1972;1422.
9. Higgins J.R., Walshe J.J., Darling M.R., Norris L., Bonnar J. Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies. Am J Obstet Gynecol. 179:1998;520-526.
10. Davey D.A., MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 158:1988;892-898.
11. Koppert P.W., Hoegee-de Nobel E., Nieuwenhuizen W. A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma. Thromb Haemost. 59:1988;310-315.
12. Saleh A.A., Stowers M.A., Eldridge D.M.et al. Maternal and neonatal correlation. Thromb Res. 68:1992;425-428.
13. Andrew M. Developmental hemostasis. relevence to hemostatic problems during childhood Sem Thromb Hemost. 21:1995;341-356.
14. Schneider D.M., von Tempelhoff G.F., Herrle B., Heilmann L. Maternal and cord blood hemostasis at delivery. J Perinat Med. 25:1997;55-61.
15. Reverdiau-Moalic P., Delahousse B., Body G., Bardos P., Leroy J., Gruel Y. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood. 88:1996;900-906.
16. Friedman S.A., Schiff E., Emeis J.J., Dekker G.A., Kao L., Sibai B.M. Fetal plasma levels of cellular fibronectin as a measure of fetal endothelial involvement in preeclampsia. Obstet Gynecol. 89:1997;46-48.
17. Davidge S.T., Signorella A.P., Lykins D.L., Gilmour C.H., Roberts J.M. Evidence of endothelial activation and endothelial activators in cord blood of infants of preeclamptic women. Am J Obstet Gynecol. 175:1996;1301-1306.